GRAIL Faces Investor Lawsuit After Stock Plunge

GRAIL, Inc. is in hot water after its stock took a nosedive, dropping over 50% when their NHS-Galleri cancer trial did not meet its main goal. Investors are now in a tizzy, filing a class action lawsuit claiming GRAIL misled them, potentially violating federal securities laws. The deadline to join the lawsuit is August 4, so if you're holding onto GRAIL stock, you might want to get in on the action. What does it mean for you? If you've invested in GRAIL, this could be your chance to get some legal backup and possibly recoup some losses, but act fast because the clock is ticking on that August 4 deadline.